02/14/2019
2:45 PM | Nightstar Therapeutics (Subject)
Woodford Investment Management Ltd (Filed by)
| Form SC 13G
|  |
02/14/2019
2:04 PM | Nightstar Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/13/2019
4:06 PM | Nightstar Therapeutics (Subject)
Syncona Portfolio Ltd (Filed by)
| Form SC 13G/A
| |
02/13/2019
3:54 PM | Nightstar Therapeutics (Issuer)
Syncona Holdings Ltd (Reporting)
Syncona Investment Management Ltd (Reporting)
Syncona Ltd (Reporting)
Syncona Portfolio Ltd (Reporting)
| Form 3/A
| |
02/12/2019
8:31 AM | Nightstar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/29/2019
8:07 PM | MOTT DAVID M (Reporting)
Nightstar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
8:06 PM | Nightstar Therapeutics (Issuer)
Whitcup Scott M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
8:05 PM | McArthur James G (Reporting)
Nightstar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
8:03 PM | Lubner David Charles (Reporting)
Nightstar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
8:02 PM | Hollowood Christopher J (Reporting)
Nightstar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
8:00 PM | Cobb Paula K (Reporting)
Nightstar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2019
8:06 PM | Nightstar Therapeutics (Issuer)
Yoon Seokho Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2019
8:05 PM | Nightstar Therapeutics (Issuer)
Sundaram Senthil Vel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2019
8:04 PM | Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2019
8:03 PM | Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2019
8:01 PM | FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2019
8:13 PM | Nightstar Therapeutics (Issuer)
Sundaram Senthil Vel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2019
8:12 PM | Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2019
8:12 PM | Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2019
8:10 PM | FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2019
8:09 PM | Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
| Form 4/A
| |
01/09/2019
8:08 PM | Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
| Form 4/A
| |
01/09/2019
8:05 PM | Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
| Form 3/A
| |
01/09/2019
8:03 PM | FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
| Form 3/A
| |
01/07/2019
8:20 PM | Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
3:29 PM | Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
8:32 PM | MOTT DAVID M (Reporting)
Nightstar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:21 PM | BARRIS PETER J (Reporting)
BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
MAKOWER JOSHUA (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
Nightstar Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Sonsini Peter W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:10 PM | Cobb Paula K (Reporting)
Nightstar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:09 PM | Nightstar Therapeutics (Issuer)
Whitcup Scott M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:08 PM | McArthur James G (Reporting)
Nightstar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:07 PM | Lubner David Charles (Reporting)
Nightstar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:05 PM | Hollowood Christopher J (Reporting)
Nightstar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:05 PM | Nightstar Therapeutics (Issuer)
Yoon Seokho Bryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:04 PM | Nightstar Therapeutics (Issuer)
Sundaram Senthil Vel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:03 PM | Nightstar Therapeutics (Issuer)
Robinson Gregory Scott (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:02 PM | Nightstar Therapeutics (Issuer)
Ong Tuyen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:01 PM | FELLOWS DAVID A (Reporting)
Nightstar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2019
8:01 PM | Nightstar Therapeutics (Issuer)
Syncona Holdings Ltd (Reporting)
Syncona Ltd (Reporting)
Syncona Portfolio Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2018
4:04 PM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2018
7:27 AM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2018
7:07 AM | Nightstar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
10/09/2018
8:39 AM | New Enterprise Associates 15, L.P. (Filed by)
Nightstar Therapeutics (Subject)
| Form SC 13D/A
| |
09/28/2018
3:03 PM | Nightstar Therapeutics (Filer)
| Form 424B4
| |
09/27/2018
11:15 PM | Nightstar Therapeutics (Filer)
| Form EFFECT
| |
09/26/2018
8:58 PM | Nightstar Therapeutics (Filer)
| Form F-1/A
| |
09/25/2018
3:20 PM | Nightstar Therapeutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
09/25/2018
3:09 PM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2018
7:06 AM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2018
5:15 AM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2018
4:30 PM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2018
7:31 AM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/10/2018
8:41 AM | Nightstar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
08/07/2018
4:26 PM | Nightstar Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G
| |
07/27/2018
3:11 PM | Nightstar Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G
| |
06/14/2018
6:35 AM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/13/2018
4:15 PM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2018
7:31 AM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2018
1:54 PM | Nightstar Therapeutics (Filer)
| Form CT ORDER
| |
05/01/2018
4:16 PM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2018
4:29 PM | Nightstar Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/03/2018
4:20 PM | Nightstar Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/08/2018
9:31 AM | Nightstar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/02/2018
8:43 AM | Nightstar Therapeutics (Subject)
Syncona Portfolio Ltd (Filed by)
| Form SC 13G
| |
